Format

Send to

Choose Destination
See comment in PubMed Commons below
Leuk Lymphoma. 2007 Aug;48(8):1482-95.

Incidence, risk factors, and pathogenesis of second malignancies in patients with non-Hodgkin lymphoma.

Author information

1
Huntsman Cancer Hospital, University of Utah, UT 84112-5560, USA. Jonathan.Tward@hci.utah.edu

Abstract

Most Non-Hodgkin's Lymphoma patients will survive their diagnosis. High dose chemotherapy and autologous stem cell transplantation, and radiation therapy have all been implicated as risk factors to secondary cancer development. Herein, we will review the molecular biology, examine the epidemiologic findings, discuss the impact of both chemotherapy and radiotherapy, and focus on the special populations of pediatrics and high dose chemotherapy and autologous stem cell transplantation with regard to secondary cancer development.

PMID:
17701578
DOI:
10.1080/10428190701447346
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Taylor & Francis
    Loading ...
    Support Center